Trial Profile
Open-label Adjunctive Zonisamide for Bipolar Disorder
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 15 Dec 2015
Price :
$35
*
At a glance
- Drugs Zonisamide (Primary)
- Indications Bipolar I disorders; Bipolar II disorders
- Focus Adverse reactions; Therapeutic Use
- Sponsors Elan Pharmaceuticals
- 15 Dec 2015 New trial record